10x Genomics, Inc.
TXG · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $643M | $611M | +5.2% |
| Operating income | −$61.0M | −$195M | +68.7% |
| Net income | −$43.5M | −$183M | +76.2% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 6, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $151M | $149M | +1.1% |
| Operating income | −$16.1M | −$32.2M | +50.0% |
| Net income | −$19.4M | −$27.5M | +29.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was 10x Genomics's revenue in FY2025?
- $643M in FY2025 (Fiscal year ended Dec 31, 2025), +5.2% vs $611M a year earlier, per its 10-K filed Feb 2026.
- Was 10x Genomics profitable in FY2025?
- No: net income was −$43.5M and operating income −$61.0M in FY2025.
- What was 10x Genomics's revenue in Q3 2026?
- $151M (+1.1% vs a year earlier), per its Form 10-Q filed Nov 6, 2026.